Corporate Overview
PDS Biotech is a clinical stage biopharmaceutical company with a growing pipeline of cancer immunotherapies and infectious disease vaccines. Our team is committed to developing first-in-class T cell activating immunotherapies to fight against cancer and to provide more rapid and longer-lasting protection against infectious diseases.
| 3 | Proprietary T cell activating platforms |
| 4 | Ongoing clinical trials; 3 Phase 2 trials 1 Phase 3 trial |
| World class partnerships |
With Merck, MD Anderson Cancer Center, National Cancer Institute and Mayo Clinic |
Latest News
Quick Links
SEC Filings
Governance
Documents
Stock Info
Analyst Coverage
FAQs